Trial intelligence / Profile preview

Bedaquiline (TMC207) in Newly Diagnosed Pulmonary Tuberculosis

NCT01215110Phase 2Completed

Sponsor
TB Alliance
Start
Apr 2010
Primary completion
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bedaquiline in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Apr 2010; status: completed.

02

Drugs

bedaquiline
03

Conditions

pulmonary tuberculosis (TB)

Beyond the preview

Go deeper on NCT01215110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01215110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call